| Product Code: ETC8041760 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of gemcitabine hydrochloride to Lithuania in 2024 continued to see high concentration among top exporting countries, with Germany, China, Canada, USA, and Poland leading the way. The Herfindahl-Hirschman Index (HHI) indicated a significant increase in market concentration from 2023 to 2024, reaching very high levels. Despite a strong compound annual growth rate (CAGR) of 44.85% from 2020 to 2024, there was a slight decrease in the growth rate from 2023 to 2024 at -8.61%. This data suggests a dynamic market landscape for gemcitabine hydrochloride imports in Lithuania.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Lithuania Gemcitabine Hydrochloride Market Overview |
3.1 Lithuania Country Macro Economic Indicators |
3.2 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, 2021 & 2031F |
3.3 Lithuania Gemcitabine Hydrochloride Market - Industry Life Cycle |
3.4 Lithuania Gemcitabine Hydrochloride Market - Porter's Five Forces |
3.5 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Lithuania Gemcitabine Hydrochloride Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Lithuania |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Rising adoption of innovative cancer treatment methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High cost associated with gemcitabine hydrochloride treatment |
4.3.3 Limited awareness about the benefits of gemcitabine hydrochloride therapy |
5 Lithuania Gemcitabine Hydrochloride Market Trends |
6 Lithuania Gemcitabine Hydrochloride Market, By Types |
6.1 Lithuania Gemcitabine Hydrochloride Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, By Injection, 2021- 2031F |
6.1.4 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, By Solution, 2021- 2031F |
6.2 Lithuania Gemcitabine Hydrochloride Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, By Non-small Cell Lung Cancer, 2021- 2031F |
6.2.4 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.2.5 Lithuania Gemcitabine Hydrochloride Market Revenues & Volume, By Others, 2021- 2031F |
7 Lithuania Gemcitabine Hydrochloride Market Import-Export Trade Statistics |
7.1 Lithuania Gemcitabine Hydrochloride Market Export to Major Countries |
7.2 Lithuania Gemcitabine Hydrochloride Market Imports from Major Countries |
8 Lithuania Gemcitabine Hydrochloride Market Key Performance Indicators |
8.1 Patient survival rates post gemcitabine hydrochloride treatment |
8.2 Number of clinical trials conducted on gemcitabine hydrochloride |
8.3 Adoption rate of gemcitabine hydrochloride compared to traditional cancer treatments |
9 Lithuania Gemcitabine Hydrochloride Market - Opportunity Assessment |
9.1 Lithuania Gemcitabine Hydrochloride Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Lithuania Gemcitabine Hydrochloride Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Lithuania Gemcitabine Hydrochloride Market - Competitive Landscape |
10.1 Lithuania Gemcitabine Hydrochloride Market Revenue Share, By Companies, 2024 |
10.2 Lithuania Gemcitabine Hydrochloride Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |